Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial

PURPOSE: The aim of this study was to compare the effect of omeprazole plus mosapride combination therapy with that of omeprazole monotherapy in proton pump inhibitor (PPI) refractory gastroesophageal reflux disease (GERD) patients. PATIENTS AND METHODS: Patients were eligible to participate in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirinawasatien, Apichet, Kantathavorn, Nontapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667351/
https://www.ncbi.nlm.nih.gov/pubmed/31440072
http://dx.doi.org/10.2147/CEG.S214677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667351/
https://www.ncbi.nlm.nih.gov/pubmed/31440072
http://dx.doi.org/10.2147/CEG.S214677

Ejemplares similares